Skip to main content

Bacteriophage: Mr. Nice Guys of the Virus World

 It's widely accepted that HIV, Hepatitis C, Ebola, and the ongoing coronavirus have acquired a bad reputation for viruses due to their aggressive and infectious nature. But actually, there are nice guys in the virology world, microscopic bacteriophages. Different from dreadful bad viruses that will invade the host cell to take over the cellular machinery, release more infectious viral particles, and finally cause illness, phages are protective viruses that can attack and destroy bacteria.

 

About Phages

 

Bacteriophage, or known as phage, whose name is derived from the Greek word phagein, indicating the eater of bacteria. These spidery-looking viruses have a population of over 1031, larger than the total number of all other organisms, including bacteria, remaining the most abundant life-form on the planet. They could be found almost everywhere bacteria exist, including water, air, soil, the mucous membrane lining of digestive, respiratory, and reproductive tracts in bodies.

 

Phages are generally classified into virulent and temperate phages according to whether they cause host cell lysis. Virulent phages kill bacteria by infecting bacteria and lysing host cells, while the temperate bacteriophages integrate genes into bacterial DNA, which will synchronously replicate with hosts' DNA without causing cell lysis.

 

Bacteriophages As Therapy

 

With the powerful nature of killing bacteria and the undeniable fact that antibiotic-resistant infections are increasingly causing deaths, phages are chosen as the potential anti-bacterial therapies.

 

Compared to antibiotic treatments, bacteriophage therapy represents more excellence in different aspects. One obvious upside to phage therapy is that no obvious side effect is observed in the patients. Different from antibiotics that work on all bacteria, including the good ones, phages only attack a specific type or group of bacteria. Besides, phage-based therapies do not depend on dosage so much.

 

Although bacteria will also develop resistance to phages to survive, it takes less time to develop new phage therapies than novel antibiotic development. Moreover, the biological nature of phages enables them to evolve along with bacteria if they adjust to escape from the phages.

 

Phages have been allowed to treat dysentery, sepsis caused by Staphylococcus aureus, salmonella infections, and skin infections in some European and Asia countries and are approved by the FDA and USDA in the USA for treating processed poultry and meat products.

 

The Future of Phages

 

Public usage of phages as therapeutics still is an open case due to lack of research. However, it's undeniable that both unmodified and engineered phages keep attracting researchers in various fields. For instance, researchers use phage display to modify and isolate antibodies for in vitro and in vivo diagnostic and therapeutic purposes. Furthermore, phage or phage display vaccines could contribute to treating bacterial and viral pathogens, as well as cancer diseases. To sum up, bacteriophages are the Mr. nice guys in the virus world in the forms of reporter phages, labeled phages, therapeutic phages, etc.

Labels:

Comments

Post a Comment

Popular posts from this blog

Primary Antibody vs. Secondary Antibody, How to Choose?

  Antibodies (or immunoglobulins) are Y -shaped glycoproteins released by the immune system  to detect and bind to "foreign" substances , known as " antigens ", triggering a cascade of actions to destroy these foreign invaders. Scientists would develop different antibodies for research use, which basically can be classified into primary and secondary antibodies . However, how to choose the right type of antibodies for different immunoassays in experiment procedures, such as western blotting (WB), enzyme-linked immunosorbent assays (ELISA), and immunoprecipitation (IP), is one of the most common questions for green hands in the laboratory.   P rimary A ntibod y vs. Secondary Antibody   Antibodies could be categorized into two types based on the binding capability and experimental applications— primary   antibodies   and  secondary antibodies.   The main difference between these two types of antibodies is that primary antibody binds specifically to ...
Post a Comment
Read more

How Haptens Differ from Antigens and Become Immunogens?

The  difference between antigens vs. haptens  is one the most concerning issues for people who are not familiar with them. As a matter of fact, antigens and haptens are similar in many ways. They are both molecules triggering immune responses and acting as antigenic agents. And they both work as immunogens and bind to antibodies although haptens in a different manner.   What distinguishes an antigen mostly from a hapten is that antigens are complete molecules spontaneously triggering immune response whereas haptens are fragmentary small molecules that are unable to elicit immune responses unless they are conjugated to a larger molecule, known as a carrier.   What are Antigens? Antigen s, including proteins, peptides, and polysaccharides, are immunogen   molecules  that can trigger immune response s or naturally bind to   immune   components . An antigen may have one or more epitopes, which are the determinants of recognition and binding to antibod...
Post a Comment
Read more

Single-cell Genomics Study Elucidates Human Cytomegalovirus Infection

  I nfection of β-herpesvirus h uman cytomegalovirus (HCMV) could be life-threatening or cause life-long suffering in the majority of humans. Moreover, the viral vertical transmission during pregnancy leads to most congenital birth defects. However, treatment and prevention options currently available are extremely   limited.   Challenges  in Studying HCMV–host Cell Interactions   More than 235 kbp of double-stranded DNA (dsDNA)  in HCMV make s the largest known genome of human herpesviruses. Besides, HCMV is similar to other herpesviruses with complicated transcriptional architecture, including alternative transcription start sites, alternative splicing events, and polycistronic transcripts. The complex transcriptional architecture enables strict temporal control of gene expression and the possibility of generating multiple distinct proteins from a single genomic locus. The complexity is further increased by host cellular heterogeneity and differences in i...
Post a Comment
Read more